Translated ClinicalThought

Share

Program Content

Activities

  • 子宫内膜癌 IO
    子宫内膜癌分子学重新分类:确定适合接受免疫治疗的患者
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 26, 2021

    Expires: March 25, 2022

  • 子宮内膜がん IO
    子宮体癌の分子再分類:免疫療法の対象となる患者の特定
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 30, 2021

    Expires: March 29, 2022

  • Cancro endometriale IO
    Riclassificazione molecolare del cancro dellendometrio: identificazione dei pazienti idonei per limmunoterapia
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 29, 2021

    Expires: April 28, 2022

  • ICI en CE avanzado/recurrente
    Gestione del tumore endometriale avanzato o ricorrente con inibitori del checkpoint immunitario
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 28, 2021

    Expires: July 27, 2022

  • 進行/再発 EC における ICI
    免疫チェックポイント阻害剤を用いた進行・再発子宮体癌治療について
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 28, 2021

    Expires: July 27, 2022

  • ICI 治疗晚期/复发性子宫内膜癌 (EC)
    使用免疫检测点抑制剂治疗晚期或复发性子宫内膜癌
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 29, 2021

    Expires: July 28, 2022

  • ICI en CE avanzado/recurrente
    Manejo de cáncer de endometrio avanzado o recurrente con inhibidores de puntos de control inmunológico.
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 29, 2021

    Expires: July 28, 2022

  • Inmunoterapia contra el cáncer de endometrio
    Reclasificación molecular del cáncer de endometrio: Identificación de pacientes elegibles para la inmunoterapia
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022
  • ICI pour les cancers de lendomAtre
    Prise en charge des cancers de la۪endomA tre avanc̩s ou en rechute par les inhibiteurs des points de contrAle immunitaire.
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022
  • Immuno-oncologie du cancer de lendomA tre
    Reclassification moléculaire du cancer de lendomAtre: identification des patientes susceptibles de bA©nA©ficier de limmunothA©rapie.
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

Faculty

cover img faculity

Maria-Pilar Barretina-Ginesta, MD

Associate Professor
Medical Sciences Department
Girona University
Assistant Chief
Medical Oncology Department
Institut Catala D Oncologia
Girona, Spain

cover img faculity

Domenica Lorusso, MD, PhD

Associate Professor 
Catholic University of Sacred Heart
Haear of Clinical Research Development Unit
Fondazione Policlinico Gemelli IRCCS
Rome, Italy

Supporters

Supported by an educational grant from

GlaxoSmithKline